Alerts will be sent to your verified email
Verify Email
FDC
|
FDC
|
Marksans Pharma
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.66 % | 17.57 % | 23.7 % |
|
5yr Avg Net Profit Margin
|
16.24 % | 14.56 % | 12.9 % |
|
Price to Book
|
3.26 | 3.09 | 3.24 |
|
P/E
|
27.65 | 21.74 | 22.78 |
|
5yr Avg Cash Conversion Cycle
|
-14.0 Days | 71.65 Days | -51.45 Days |
|
5yr Average Interest Coverage Ratio
|
90.41 | 38.03 | 0.72 |
|
5yr Avg ROCE
|
14.95 % | 21.95 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
18.97 % | 20.32 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.0 | 0.02 | 1.01 |
|
5yr CAGR Net Profit
|
-2.41 % | 10.03 % | 68.01 % |
|
5yr Average Return on Assets
|
8.73 % | 13.19 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.66 % | 43.87 % | 28.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 50.1 % |
|
Change in Promoter Holding (3 Yrs)
|
0.16 % | -4.38 % | -2.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.1 % | 2.6 % | -0.99 % |
|
FDC
|
Marksans Pharma
|
Strides Pharma Scien
|
|---|